ReviewClinical cancer research : an official journal of the American Association for Cancer Research2010

Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosis.

Srdan VerstovsekPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.